C12N 2760/16223
Virus like particles [vlp]
Official title: Virus like particles [VLP]
C12N2760/16223 (Virus like particles [vlp]) appears on 36 US grants and 54 published applications in this corpus.
Search patents in C12N- Granted patents
- 36
- Published applications
- 54
- Assignees
- 25
- Inventors
- 67
- Latest grant
- 11 Nov 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2007 | 0 | 1 |
| 2008 | 0 | 0 |
| 2009 | 0 | 1 |
| 2010 | 0 | 3 |
| 2011 | 0 | 4 |
| 2012 | 0 | 1 |
| 2013 | 2 | 5 |
| 2014 | 1 | 1 |
| 2015 | 2 | 6 |
| 2016 | 6 | 2 |
| 2017 | 1 | 6 |
| 2018 | 5 | 3 |
| 2019 | 4 | 4 |
| 2020 | 4 | 6 |
| 2021 | 4 | 0 |
| 2022 | 2 | 5 |
| 2023 | 0 | 1 |
| 2024 | 3 | 2 |
| 2025 | 2 | 2 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Influenza virus-like particle production in plants11 Nov 2025US 12,467,058 B2Aramis Biotechnologies Inc.
- Proliferation method20 May 2025US 12,305,197 B2Kao Corporation
- Endogenous plant expression enhancer19 Nov 2024US 12,146,145 B2Aramis Biotechnologies Inc.
- Engineered influenza antigenic polypeptides and immunogenic compositions thereof16 Jul 2024US 12,037,364 B2Sanofi Pasteur Limited
- Headless hemagglutin influenza vaccine2 Apr 2024US 11,945,841 B2Gerogia State University Research Foundation, Inc.
- Influenza virus vaccines and uses thereof1 Jan 2026US 2026/0000747 A1Icahn School of Medicine at Mount Sinai
- Multivalent display on enveloped particles with human oligomerization domains18 Sep 2025US 2025/0288662 A1Achelois Biopharma, Inc.
- Endogenous plant expression enhancer26 Jun 2025US 2025/0207144 A1Aramis Biotechnologies Inc.
- Influenza vaccine compositions and methods of using same11 Jul 2024US 2024/0226267 A9Children's Hospital Medical Center
- Influenza vaccine compositions and methods of using same25 Apr 2024US 2024/0131145 A1Children's Hospital Medical Center
Most cited
By later US patents
- Influenza virus vaccines and uses thereof19US 9,371,366 B2Icahn School of Medicine at Mount Sinai · 2016
- Generation of infectious influenza viruses from virus-like particles18US 10,494,613 B2Wisconsin Alumni Research Foundation (WARF) · 2019
- Avian influenza chimeric VLPS18US 8,551,756 B2Novavax, Inc. · 2013
- Generation of infectious influenza viruses from virus-like particles16US 11,180,737 B2Wisconsin Alumni Research Foundation (WARF) · 2021
- Highly efficient influenza matrix (M1) proteins12US 8,992,939 B2Novavax, Inc. · 2015